Skip to content

Platelet Rich Plasma in Plantar Fasciitis

Musculoskeletal Ultrasound Changes in the Plantar Fascia After a Single Injection of Platelet Rich Plasma Compared to Steroid

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05339542
Acronym
PRP
Enrollment
98
Registered
2022-04-21
Start date
2022-03-10
Completion date
2022-07-02
Last updated
2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fascitis

Keywords

degenerative plantar fasciitis, platelet rich plasma, ultrasound guided injection, heel pain, interventional rheumatology

Brief summary

a number of patient diagnosed as degenerative plantar fasciitis will be collected and divided into two groups, group I will be injected by platelet rich plasma and group II will be injected methylprednisolone

Detailed description

the study will include 100 patients diagnosed as degenerative plantar fasciitis and will be evaluated by musculoskeletal ultrasound by two observes and the will divided randomly into two groups who will be injected under ultrasound imaging by either Platelet rich plasma or methylprednisolone. selection of patient will be randomly and the study will be double blinded.

Interventions

OTHERplatelet rich plasma

derived from patient own blood

active comparative intervention

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

the study will include two groups. Group I (study group) will be injected PRP. Group II (control group) will be injected methylprednisolone

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\* Clinical diagnosis of plantar fasciitis

Exclusion criteria

(history or current): * Rheumatic diseases * Foot Trauma * Neurological diseases * Thyroid disease * Diabetes mellitus * Chronic Renal Failure

Design outcomes

Primary

MeasureTime frameDescription
visual analogue scale3 monthsvisual analogue scale from 0-10, where 0 denoting maximum pain relief and 10 denoting no pain relief
Manchester-Oxford Foot Questionnaire3 monthsthe Manchester-Oxford Foot Questionnaire is a 16-item instrument answered on a five-point Likert scale (each item is scored from 0 to 4, with 4 denoting 'most severe'). Scores for each item are summed to form three separate sub scales representing underlying domains: walking/standing problems (seven items), foot pain (five items), and issues related to social interaction (four items)

Secondary

MeasureTime frameDescription
echogenicity in longitudinal scan gray scale ultrasound3 monthsHypoechogenicity was defined as a lack of the homogeneous fibrillar pattern with loss of the tightly packed echogenic lines after correcting for anisotropy. increased echogenicity is consistent with plantar fasciitis
plantar fascia thickness at the insertion in longitudinal scan of the heel3 monthsmeasurement of plantar fascia thickness at the insertion in longitudinal view of the heel. Normal thickness is ≤ 4mm. increased thickness is consistent with plantar fasciitis

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026